Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Webuild SpA ( (IT:WBD) ).
Webuild SpA has secured a AUD 1.8 billion contract for the construction of the Women and Babies Hospital in Perth, Australia, marking a significant expansion in the healthcare sector. This project, commissioned by the Western Australia Government, aims to replace the King Edward Memorial Hospital and enhance healthcare services in the region. The contract strengthens Webuild’s presence in Australia, its second-largest market, and underscores its capability in delivering complex infrastructure projects, further solidifying its position in the industry.
The most recent analyst rating on (IT:WBD) stock is a Buy with a EUR3.20 price target. To see the full list of analyst forecasts on Webuild SpA stock, see the IT:WBD Stock Forecast page.
More about Webuild SpA
Webuild SpA is a global leader in the design and construction of large complex infrastructures, focusing on sustainable mobility, hydroelectric energy, water management, and green buildings. With operations in about 50 countries and a workforce of over 92,000 people, the company has completed over 3,700 projects, including significant contributions to railways, roads, bridges, and tunnels worldwide. Webuild is recognized for its expertise in the water sector and is listed on the Milan Stock Exchange.
Average Trading Volume: 2,123,908
Technical Sentiment Signal: Buy
Current Market Cap: €3.66B
For a thorough assessment of WBD stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue